Header Logo

MOHAMMED N AL HALLAK

TitleAssistant Professor
InstitutionMD Anderson
DepartmentGeneral Internal Medicine
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Heath E, Dyson G, Ribeiro JR, Xiu J, Poorman K, Mamdani H, Al Hallak MN, Shields AF, Elayoubi JA, Winer IS, Cackowski FC, Puckrein GA, Lopes GL, Jones N, Hauke RJ, Kareff SA, Radovich M, Sledge GW, Spetzler DB, Vidal GA, Marshall JL, Heath E, Dyson G, Ribeiro JR, Xiu J, Poorman K, Mamdani H, Al-Hallak MN, Shields AF, Elayoubi JA, Winer IS, Cackowski FC, Puckrein GA, Lopes GL, Jones N, Hauke RJ, Kareff SA, Radovich M, Sledge GW, Spetzler DB, Vidal GA, Marshall JL. Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy. Cancer Res Commun. 2024 Oct 01; 4(10):2598-2609. PMID: 39172022; PMCID: PMC11450693.
      Citations:    Fields:    Translation:Humans
    2. Kim DW, Schram AM, Hollebecque A, Nishino K, Macarulla T, Rha SY, Duruisseaux M, Liu SV, Al Hallak MN, Umemoto K, Wesseler C, Cleary JM, Springfeld C, Neuzillet C, Joe A, Jauhari S, Ford J, Goto K. The phase I/II eNRGy trial: Zenocutuzumab in?patients with cancers harboring NRG1 gene fusions. Future Oncol. 2024; 20(16):1057-1067. PMID: 38348690.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    3. Cobani E, Al Hallak MN, Shields AF, Maier J, Kelly TE, Naidoo N, Tobon M, Kim S, Beal EW. Gastric Cancer Survivorship: Multidisciplinary Management, Best Practices and Opportunities. J Gastrointest Cancer. 2024 Jun; 55(2):519-533. PMID: 38180678.
      Citations: 1     Fields:    Translation:Humans
    4. Khan HY, Nagasaka M, Aboukameel A, Alkhalili O, Uddin MH, Bannoura SF, Mzannar Y, Azar I, Beal EW, Tobon ME, Kim SH, Beydoun R, Baloglu E, Senapedis W, El-Rayes BF, Philip PA, Mohammad RM, Shields AF, Al Hallak MN, Azmi AS. Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers. Mol Cancer Ther. 2023 Dec 01; 22(12):1422-1433. PMID: 37703579; PMCID: PMC10690049.
      Citations:    
    5. Almujarkesh MK, Damughatla AR, Bathla J, Sugg K, LaBuda D, Alkassis S, Al Hallak MN. Primary Squamous Cell Biliary Carcinoma With Liver Metastasis Is Rare but Malicious. Gastroenterology Res. 2023 Oct; 16(5):276-279. PMID: 37937226; PMCID: PMC10627356.
      Citations:    
    6. Azar I, Alkassis S, Fukui J, Alsawah F, Fedak K, Al Hallak MN, Sukari A, Nagasaka M. Spotlight on Trastuzumab Deruxtecan (DS-8201,T-DXd) for HER2 Mutation Positive Non-Small Cell Lung Cancer. Lung Cancer (Auckl). 2021; 12:103-114. PMID: 34675733; PMCID: PMC8507417.
      Citations:    
    7. Nagasaka M, Asad MFB, Al Hallak MN, Uddin MH, Sukari A, Baca Y, Xiu J, Magee D, Mamdani H, Uprety D, Kim C, Xia B, Liu SV, Nieva JJ, Lopes G, Bepler G, Borghaei H, Demeure MJ, Raez LE, Ma PC, Puri S, Korn WM, Azmi AS. Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC). Lung Cancer. 2021 10; 160:92-98. PMID: 34482103; PMCID: PMC8853639.
      Citations:    
    8. Li Y, Al Hallak MN, Philip PA, Azmi AS, Mohammad RM. Non-Coding RNAs in Pancreatic Cancer Diagnostics and Therapy: Focus on lncRNAs, circRNAs, and piRNAs. Cancers (Basel). 2021 Aug 19; 13(16). PMID: 34439315; PMCID: PMC8392713.
      Citations:    
    9. Al-Share B, Alloghbi A, Al Hallak MN, Uddin H, Azmi A, Mohammad RM, Kim SH, Shields AF, Philip PA. Gastrointestinal stromal tumor: a review of current and emerging therapies. Cancer Metastasis Rev. 2021 06; 40(2):625-641. PMID: 33876372.
      Citations:    
    10. Sexton RE, Al Hallak MN, Diab M, Azmi AS. Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev. 2020 12; 39(4):1179-1203. PMID: 32894370; PMCID: PMC7680370.
      Citations:    
    11. El Mouhayyar C, Chehab O, Khalil E, Al Hallak MN, Kanj A, Bishop C. Paraneoplastic leukemoid reaction in a patient with metastatic adenocarcinoma of the lung. Clin Case Rep. 2020 Jan; 8(1):9-12. PMID: 31998477; PMCID: PMC6982483.
      Citations:    
    12. Hrad V, Abebe Y, Ali SH, Velgersdyk J, Al Hallak M, Imam M. Risk and Surveillance of Cancers in Primary Biliary Tract Disease. Gastroenterol Res Pract. 2016; 2016:3432640. PMID: 27413366; PMCID: PMC4930812.
      Citations:    
    13. Risk and surveillance of cancers in primary Biliary tract disease. Gastroenterology Research and Practice. 2016.
    14. Primary submucosal squamous cell carcinoma of the rectum diagnosed by endoscopic ultrasound. Case Reports in Gastroenterology. 4:243-249.
    AL HALLAK's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (50)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _